• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    10/8/25 5:13:39 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    false 0001883788 0001883788 2025-10-07 2025-10-07 0001883788 DHAI:ClassCommonStockMember 2025-10-07 2025-10-07 0001883788 DHAI:WarrantsMember 2025-10-07 2025-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 7, 2025

     

    DIH HOLDING US, INC.

    (Exact name of Registrant as Specified in Its Charter)

     

    Delaware   001-41250   98-1624542

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    77 Accord Park Drive;

    Suite D-1

    Norwell, Massachusetts

      02061
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 877 944-2200

     

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
         
      ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
         
      ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
         
      ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Class A Common Stock   DHAI   The Nasdaq Stock Market LLC
    Warrants   DHAIW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    As previously disclosed, on April 4, 2025, the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notified DIH Holding US, Inc. (the “Company”) that for the previous 30 consecutive trading days the market value of its publicly held shares had been below the minimum $15,000,000 required for continued listing as set forth in Listing Rule 5450(b)(2)(C) (the “MVPHS Rule”). Therefore, in accordance with Marketplace Rule 5810(c)(3)(D), the Company was provided 180 calendar days, or until October 1, 2025, to regain compliance with the Rule. The Company has not regained compliance with the Rule. Accordingly, this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market.

     

    On October 7, 2025, (the “October Letter”) the Company received formal notification from the Staff that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Company’s continued listing on The Nasdaq Global Market. The October Letter provided that pursuant to Listing Rule 5810(d), the Company should present its views with respect to this additional deficiency at its Panel hearing. If the Company fails to address the aforementioned issue, the Panel will consider the record as presented at the hearing and will make its determination based upon that information.

     

    As previously disclosed, on March 5, 2025, the Company received written notice from Staff which notified the Company that, for the previous 30 consecutive business days prior to the date of the MVLS Notice, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided with a compliance period of 180 calendar days in which to regain compliance with the MVLS continued listing requirement, or until September 1, 2025. The Company did not regain compliance with the MVLS Rule by September 1, 2025, and, accordingly, by letter dated September 2, 2025, the Staff notified the Company that its securities were subject to delisting from Nasdaq unless the Company timely requests a hearing before the Panel.

     

    As previously disclosed, on March 11, 2025, the Company received written notice from Staff which notified the Company that the bid price of its Class A common stock had closed at less than $1.00 per share for the previous 30 consecutive business days prior to the date of the Bid Price Notice, as required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided with a compliance period of 180 calendar days in which to regain compliance with the Bid Price Rule, or until September 8, 2025. The Company did not regain compliance with the Bid Price Rule by September 8, 2025, and, accordingly, by letter dated September 12, 2025, the Staff notified the Company that this matter would serve as an additional basis for delisting, so it would need to address it before the Panel.

     

    The Company has requested a hearing before the Panel, which has stayed the suspension of the Company’s Common Stock for a period of 15 days. In connection with this request, the Company also requested an extended stay of any further action pending the hearing (the “Additional Stay”) due to its non-compliance with the (the “Reports Rule”) as referenced in an additional basis for delisted dated September 12, 2025, since it has not filed its Form 10-Q for the period ended June 30, 2025 and Form 10-K for the period ended March 31, 2025. At the hearing, the Company will present its plan to evidence compliance with all applicable listing criteria, including the MVPHS Rule, the MVLS Rule, the Bid Price Rule and the Reports Rule, and request an extension of time. The Panel has the authority to grant the Company an extension of up to 180 days from the date of the Staff’s delist determination for the MVPHS, MVLS, and Bid Price Rules and 360 days from the initial filing delinquency. The Company is considering all options available to it to regain compliance with the MVPHS Rule, MVLS Rule, the Bid Price Rule and the Reports Rule; however, there can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to evidence compliance within the period of time that may be granted by the Panel.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      DIH HOLDING US, INC.
         
    Date: October 8, 2025 By: /s/ Jason Chen
       

    Jason Chen

    Chief Executive Officer and Chairman

     

     

     

    Get the next $DHAI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter

    NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule"), so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the "Reports Rule"),

    10/1/25 8:11:40 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Receives Additional Nasdaq Staff Determination Letter

    DIH Receives Notice of Additional Basis for Delisting from The Nasdaq Stock Market DIH Has Requested Hearing to Appeal before Nasdaq Hearing Panel NORWELL, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule") and, accordingly, the Staff notified the Company that this matter would serve as an additional basis for delisting. As previously disclosed, on March 11, 2025, DIH Holding US, Inc. (the "Company") receive

    9/18/25 4:10:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/8/25 5:13:39 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/1/25 9:47:41 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    9/26/25 4:30:51 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mooney Barrett claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    9/8/25 5:15:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care